Introduction
"Organotypic" approaches greatly advance our ability to recapitulate physiologically relevant biological phenomena by taking us from monocultures on flat plastic surfaces to 3D multicultures containing structure, function, and microenvironmental www.advancedsciencenews.com www.advhealthmat.de recruitment. Innate immunity is a critical part of host defense; neutrophils act as first responders by sensing chemotactic signals and migrating rapidly to sites of injury to combat infection. [11] Furthermore, neutrophil response is heavily regulated by the vasculature, and the endothelium in particular. [12] Neutrophils are not only critical for proper inflammatory response but also contribute to pathologies associated with cardiovascular disease, autoimmune disorders, and cancer. [13] As such, there is a great opportunity to target the innate immune response for therapeutic intervention, improving pathogen clearance, or limiting improper inflammatory resolution. However, precise control over geometry and the microenvironment is necessary for organotypic endothelial modeling, large-scale investigation of endothelial-regulated neutrophil recruitment, and transmigration during innate inflammation.
A recently established organotypic approach, termed Lume-NEXT, [14] provides just such control, facilitating reliable and robust creation of in vitro microvessel structures. Using LumeNEXT, size, distances, hydrogel composition, structure, and configuration (e.g., multivessel structures and branches, stromal culture) are all highly controllable using standard polydimethylsiloxane micromolding methods. When attempting to model complex systems such as immune recruitment, determining the extent to which each component contributes to a given response is difficult to quantify even in the simplest of setups. So control of cell phenotype, culture geometry, and microenvironmental conditions will need to be increasingly strict in order to single out contributors and mechanisms associated with complex physiological phenomena. For example, how do we measure how subtle changes in extracellular matrix composition alter endothelial vessel tight junctions and neutrophil extravasation events without duplicable vessel fabrication and reliable cell phenotype? Robust control of in vitro vessel model parameters will be critical, as matrix composition and mechanics has been shown to greatly influence endothelial response with self-assembled networks. [15] Thus, the advantages of LumeNEXT synergize directly with those presented by iPSC: (1) Increased tractability and reliability arises from precise culture control provided by LumeNEXT and minimal iPSCsource variability, and (2) physiological relevance is increased by organotypic design and primary-like behavior from iPSC, helping to bridge the gaps present between current in vitro methodologies and animal models.
To this end, here we characterize a repeatable, engineered endothelial vessel by coupling commercial iPSC with the robust organotypic approach with utility in a variety of biological investigations including modeling neutrophil behavior during innate immune response. Commercial iPS-derived endothelial cells demonstrated classical markers of endothelial phenotype and proved reliable from multiple lots, over several years of culture. When deployed in organotypic lumen culture, they formed patent, confluent structures and demonstrated primary-like vessel morphologies. iPSC endothelial cells provide barrier function, forming close cell-cell contact and tight junction expression, and also secrete inflammatory and angiogenic mediators. Importantly, the organotypic iPSC model proved responsive to changes in the extracellular matrix composition, showing leaky cancer-associated vessel-like phenotypes in collagen I matrices. Finally through robust expression of P-selectin, endothelial vessels also facilitate neutrophil capture and extravasation, enabling creation of tractable innate immune models. The data demonstrate the utility of coupling iPSC and the LumeNEXT organotypic method, moving toward the creation of more reliable, relevant, and widely adoptable microvessel models.
Results

Induced Pluripotent Stem Cell Derived Endothelium
Endothelial cells (ECs) derived from iPSCs are an attractive alternative cell source for organotypic models, as iPSC-derived cells can be more physiologically relevant than cell lines, while minimizing the patient-to-patient variability of primary samples. [9] However, since many labs lack the needed infrastructure or expertise for iPSC differentiation, commercially available sources are particularly important for widespread adoption of new methods. The commercially available iPSCECs used herein, termed iEC (CDI, Madison, Wisconsin), were reported to express endothelial markers and functional properties of endothelium consistent with primary cells (e.g., tumor necrosis factor alpha (TNF-α) activation, dynamic barrier function, shear stress response, and undirected capillary-like network formation in several contexts). [16] We observed significant reproducibility in culture of iEC from several lots of cells (e.g., manufacturer #1833921, #1910001) across nearly two years of use. In 2D culture, 3 d postplating, cells are 95.5 ± 2.5% cluster of differentiation 31 and 105 (CD31/CD105) double positive (platelet endothelial cell adhesion molecule 1 (PECAM-1) and endoglin, respectively) with a viability of 91%. Endoglin, a transmembrane glucoprotein, and PECAM-1, an integral membrane glycoprotein concentrated at junctions between adjacent cells, have been shown to identify vascular endothelial cells in a variety of contexts. [17] [18] [19] After 4 d in culture, cells demonstrate an average doubling time of 43.6 h. In comparison, pooled donor human umbilical vein endothelial cells (HUVECs), a well-accepted primary endothelial source, were 98% CD31/ CD105 double positive with a viability of 92% and a 23 h doubling time. Importantly, there was little observed morphological variation of different iEC lots in culture ( Figure S2 , Supporting Information). Additionally, successful expansion, freezing, and subculture could be maintained through 8 passages, though decreased proliferation and viability after passage 5 constrains passage use. Subpassaging and freezing did not observably alter, resulting in 2D or 3D culture phenotype.
LumeNEXT iPSC-Derived Vessel
The LumeNEXT approach reliably controls vessel size, distances, hydrogel composition, structure, and configuration in the creation of 3D embedded organotypic endothelial lumens using standard polydimethylsiloxane micromolding methods (Figure 1) . [14] Robust control of in vitro vessel model parameters is critical, as matrix composition and mechanics has been shown to influence endothelial response in the context of selfassembled networks. [15] Expanding on the HUVEC vessels www.advancedsciencenews.com www.advhealthmat.de formed in collagen previously, [14] LumeNEXT vessels were successfully formed in 10 mg mL −1 fibrin with HUVECs, iECs, and even primary human endothelial cells isolated from kidney tissue ( Figure 1C -E), and vessels can be maintained in culture for longer than two weeks. iEC-derived microvessels ( Figure 1E ) show parallel morphological elongation down the length of the vessel, similar to primary cells ( Figure 1D ) and vessels in vivo, even without an external shear stress from flow. This phenotype was not observed in HUVEC-derived models ( Figure 1C ).
iEC Shows Physiological Characteristics
When assessing the physiological behaviors of the model, we evaluated the organotypic vessel in the context of the in vivo function of endothelial cells. Namely, endothelial cells should provide structure by forming the inner lining of a hollow lumen, regulate passage of cells and other substances, and secrete mediators that influence vascular dynamics, inflammation, and angiogenesis. Organotypic lumens of iECs were created in 10 mg mL −1 fibrin matrices and cultured prior to fixation, staining, and fluorescent imaging (Figure 2) . iEC vessels are structurally sound, patent, confluent, and hollow, forming a lumen through which media and other fluids (such as blood) can be flowed (Figure 2A ). Endothelial cells form a monolayer surrounding the lumen and show intimate cell contact ( Figure 2B ). This endothelial barrier along the lumen also stains positive for zonula occludens-1 (ZO-1) ( Figure 2C and Figure S3 (Supporting Information)). Positive ZO-1 staining is indicative of the formation of tight junction that can regulate the passage of signaling molecules and cells [20] and also suggests a possible mature vessel phenotype. [21] The endothelial cells must also express binding proteins such, as P-selectin (CD62P), to capture and transport cells (such as neutrophils and monocytes during the innate immune response) across these tight junctions, [22] and we observed significant expression of P-selectin across the endothelial vessel surface ( Figure 2D ). Vessel size is easily LumeNEXT organotypic approach enables microvessel modeling. A) LumeNEXT devices consist of a culture chamber interfaced with four ports, across which a PDMS rod is suspended. The culture chamber is filled with a hydrogel of interest via the two side ports, and the rod is removed from the outlet utilizing tweezers, leaving behind a lumen in the hydrogel that can be accessed from an inlet and outlet. When viewed in cross-section in culture, extracellular matrix surrounds the endothelial cell lined lumen, which has been coated for cell adhesion (i.e., fibronectin) and culture media are flowed in the luminal space. Lumens can be imaged with brightfield microscopy visualizing B) empty fibrin lumens, as well as, lumens lined with C) human umbilical vein endothelial cells, D) human primary kidney endothelial cells, and E) iEC-derived endothelial cells, forming model microvessels. iEC organotypic endothelial models formed using LumeNEXT approach display key characteristics of microvessels when visualized using fluorescent Z-stack microscopy (green -P-selectin, blue -Hoechst 33342, red -ZO-1). A) iEC form the inner lining of the luminal space creating patent, confluent cellular structures through which fluids can flow. B) Cells display intimate cell-cell contact along the edge of the vessel, and C) these contacts express moderate levels of ZO-1, suggesting tight junction formation. D) Ubiquitous P-selectin expression along the surface of the endothelial enables leukocyte capture and regulation of cell adhesion on the endothelium surface for inflammation modeling applications.
www.advancedsciencenews.com www.advhealthmat.de controllable through changes in polydimethylsiloxane (PDMS) rod diameter, with vessels of 300 µm ( Figure 2 ) and 100 µm ( Figure S4 , Supporting Information) demonstrated herein. In vivo, the regulation of macromolecule transport across the endothelial vessel is controlled by vessel barrier function, and while visualization of tight junctions is suggestive of this, direct assessment via fluorescent permeability assays is a well accepted measure of barrier function in vitro. [23] Fluorescein isothiocyanate (FITC) conjugated 70 kDa dextran (SigmaAldrich, Saint Louis, Missouri) at 50 µg mL −1 was flowed into the lumen of the vessel, and the intensity was measured over time. As there is a linear relationship between fluorescence intensity and fluorophore concentration, we can achieve a measure of barrier function by calculating percent flux over time. [24] Using this method, the barrier function of empty, iEC, and HUVEC lumens was assessed ( Figure 3 ). As expected, empty (i.e., no endothelial cells) fibrin lumens displayed little to no barrier function, with significant diffusion of dextran from the lumen within 15 min ( Figure 3A ). In contrast, minimal dextran (≈7× less, Figure S5 , Supporting Information) diffused from HUVEC vessels, confirming HUVEC tight junction formation as is reported in the literature ( Figure 3B ). [25] iEC-derived vessels show an intermediate barrier phenotype (≈2× less, Figure 3C and Figure S5 (Supporting Information)) but restricted 70 kDa as well as 10 kDa ( Figure S5 , Supporting Information) macromolecule passage.
Endothelial vessels are also supported by a variety of stromal cells including fibroblasts, smooth muscle cells, and pericytes, such as in the case of microvessels. [26] In order to show functional response to coculture in our organotypic microvessel, we demonstrated increased vessel sprouting with pericyte coculture. In vivo, pericytes are smooth muscle-like cells that cover the surface of microvessels and make close contacts with the endothelial cells, [27] so primary human brain vascular pericytes (HBVPs) were loaded with endothelial cells during seeding at a 10:1 endothelial to pericytes ratio to create an endothelialpericyte coculture vessel. Vessels with and without HBVPs were exposed to 25 ng mL −1 vascular endothelial growth factor (VEGF) serum media from the side ports, and the resulting sprouting response was observed. By day 14, pericyte-rich vessels showed sprouting phenotypes, filling the entire culture chamber, while iECs alone did not ( Figure S6 , Supporting Information). HBVPs have been seen to play a significant role in the regulation of angiogenesis and the survival of endothelial cells, [28] so these results are promising. Moving forward, reproducible in vitro endothelial vessels capable of responding to vascular pericyte activity will be useful for large-scale modeling and screening of effectors of hypertension and other cardiovascular diseases. [29] Finally, the endothelial cells within a vessel not only control permeability and facilitate blood transport but also are significant paracrine signalers, contributing to coagulation, angiogenisis, and, importantly, immune response. [30] In order to evaluate the secretion profile of our organotypic vessel, Luminex multiplexed human growth and angiogenic factor protein analysis was performed. Culture media from within primary endothelial and iEC lumens were collected and analyzed over a 2 d period ( Table 1) . Cytokine secretions from iECs and primary endothelial cells in 4 mg mL −1 collagen and 10 mg mL −1 fibrin were normalized to lumens filled only with the corresponding culture media. We see the secretion of a number of important inflammatory and angiogenic regulators such as interleukin-8 (IL-8), fibroblast growth factor-2 (FGF-2), VEGFs, granulocyte colony stimulating factor (G-CSF), angiopoeitin-2, endothelin-1, hepatocyte growth factor (HGF), and endoglin. Important to note, epidermal growth factor (EGF) and VEGF-A, which were present in both culture media, were not detectable above media levels for several conditions. Additionally, significant levels of angiopoeitin-2 were detectable only in iEC vessels, in both collagen and fibrin matrices. Finally, extracellular matrix composition (collagen vs fibrin) was seen to alter secretion in both iEC and primary endothelial cells. This diversity in phenotype is expected considering the diversity in source, [31] but it should be considered when using this approach to engineer specific models that are designed to recapitulate particular physiological systems.
Adv. Healthcare Mater. 2018, 7, 1700497 Figure 3 . iEC-derived microvessels display barrier function. A) Unlined (empty) 10 mg mL −1 fibrin lumens permit diffusion of 70 kDa FITC-dextran (comparable to 66.5 kDa serum albumin) over the course of 15 min after loading a 50 µg mL −1 solution. B) In contrast, HUVEC lined model vessels restrict the passage of macromolecule-sized dextran over a 15 min time period. C) iEC-derived microvessels also restrict diffusion of 70 kDa dextran compared to empty lumens, but display a weaker barrier function compared to HUVEC-lined structures.
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ECM Composition Modulates Barrier Function
Fibrin has seen extensive use as a natural extracellular matrix (ECM) in engineered vascular models and has been successful herein. [32] However, fibrin lacks the mechanical properties of native ECM, and differences in endothelial integrin-matrix binding may alter vessel behavior as seen in the MagPix results. [33, 34] As such, we also characterized iEC vessels in collagen I matrices to assess potential differences in response. iEC in fibrin ECM organotypic vessels show strong alignment parallel to the vessel length and morpohological elongation ( Figures 1E and 4A ), as is observed with primary human endothelial cells ( Figure 1D ). This alignment is observed in the cytoskeletal organization as well, with cells taking on the physiological morphology of cells responding to shear stress in the lumen structure even without the presence of constant shear stress from flow. [35] The actin cytoskeletal organization of iEC vessels in fibrin supports our observation of tight junction behavior. Higher fluorescent signal around cell borders marks the cortical actin rim of the iEC. Cortical actin is attached to the cell membrane and is associated with cell-to-cell and cellto-matrix adhesions that hold cells in tight contact with each other and the matrix. [36, 37] The secretion of HGF that was observed from iEC may also contribute to this phenotype, as HGF has been shown to enhance cortical actin reorganization, improving barrier function. [38] There was initial concern that PDMS rods were imprinting micropatterns on the ECM surface during fabrication or from rod removal, as there are topographies on the rod surface ( Figure S7 , Supporting Information) and pulling from the matrix may impart an aligned pattern. Yet, neither fibrin nor collagen I surfaces show evidence of such alignment or patterning ( Figure S8 , Supporting Information), and HUVEC cells cultured on these surfaces show no morphological differences ( Figure 1C ). The observed actin phenotype, however, is completely disrupted in vessels formed in collagen I extracellular matrices ( Figure 4B ). Cortical actin rims are less distinct, and gaps in the endothelial vessel can be easily visualized. Endothelial cells more readily migrate out of the lumen structure as individuals, and permeability testing with 70 kDa FITC-dextran showed clear visualization of a leaky vessel phenotype ( Figure 4C ) with holes through which the macromolecules could easily diffuse. This endothelial morphology is closer to what is seen in tumor-associated endothelium [39] and may be a synergistic response to the collagen I matrix and the high levels of angiopoeitin-2 that are being secreted by the iEC (Table 1) , as angiopoeitin-2 can be associated with vessel disruption and reorganization. [40] Additionally as previously noted, collagen I matrices are less mechanically stiff than those formed with fibrin at similar concentrations, and it has been reported that endothelial cells preferentially develop more spread morphologies with stronger actin stress fibers on stiffer matrices. [41] While exact values for fibrin stiffness vary depending on preparation and source, measurements fall within the range of a few kPa for matrices in the 3-10 mg mL −1 range. [42, 43] Indeed, we obtained similar values with our own gels, measuring a stiffness of 4.7 ± 0.53 kPa for a concentration of 10 mg mL −1 via atomic force microscopy. In contrast, collagen I stiffnesses are reported in the ranges of tens to hundreds of Pascal, [44] an order of magnitude lower at least. As there are likely many contributors to this differential response that could be investigated in considerably greater detail, these observations together highlight the need for additional ECM engineering: although collagen I is a major component of adult vessel ECM, endothelial cells normally must degrade basement membrane before adopting migratory and proliferative phenotypes within interstitial spaces rich with collagens. [45] Regardless, this responsiveness to changes in microenvironmental composition can be harnessed for the creation of diverse model phenotypes.
iEC Vessels Support Neutrophil Extravasation
During the innate immune response, neutrophils extravasate through the endothelium, migrate to sites of infection and wounding following chemotactic gradients, release cytokines/ chemokines for immune activation, and suppress invading pathogens. [46, 47] It has been long established that proper innate response requires coordinated secreted and contact mediated interactions between neutrophils and the endothelium. [12, 48] Thus, providing a vessel that can capture leukocytes, modulate barrier function, and secrete mediators to support neutrophil extravastion and migration is critical. To this end, we tested the ability of our iEC vessels to support a tractable system to study neutrophil extravasation. Primary neutrophils were collected from healthy donors, purified, mixed 1:1 with media, and loaded into lumens formed 1 d prior in collagen I matrices. Matrices were formed from collagen I in this context as it has been reported that increasing concentrations of fibrin inhibit the ability of neutrophils to migrate through a matrix, [49] though preliminary testing indicates that extravasation and migration of Table 1 . MagPix analysis of in vitro vessel secretion. Inflammatory and angiogenic cytokine secretion is visualized as a logarithmic heatmap (n = 3, pooled samples over 2 d). Color scale represents secretion levels with the background normalized by subtracting the contributions of blank (no endothelial cells) collagen or fibrin lumens. Blanks for primary endothelial cells and iEC were filled with the growth media of primary endothelial cells or iEC, respectively. Analytes that were undetectable or below the levels present in the media were excluded and displayed as a crossed out blank. Angiopoietin-2, G-CSF, IL-8, FGF-2 with iECs exceeded 10 3 relative secretion.
www.advancedsciencenews.com www.advhealthmat.de neutrophils from vessels in fibrin is possible over longer times of observation (overnight) ( Figure S9 , Supporting Information). Exogenous sources of IL-8 (11 × 10 −6 m) or N-formylmethionine-leucyl-phenylalanine (fMLP) (10 × 10 −6 m) were added to a side port, generating a gradient across the iEC lumen. Neutrophil chemotaxis was observed in the lumen over the course of 1 h. Neutrophils were flowed into the lumen via passive pumping for capture, but no flow was present during extravasation and migration. In the presence of iEC, we observed increased neutrophil chemotaxis to IL-8, compared to fMLP (Figure 5A,C) . Despite the finding that the vessels themselves robustly secrete IL-8, resulting in a shallower gradient when IL-8 is used as the chemoattractant, significantly more neutrophils extravasated (≈8×) and migrated further (4×) under this condition ( Figure 5C ). When this assay was also repeated with whole blood as a neutrophil source mixed 1:1 with media, this trend appeared to reverse with a greater effects observed with fMLP ( Figure 5B,D) . This reversal coincided with a reduced chemotactic effect (ratio of number migrating toward vs away) observed when using whole blood as well ( Figure 5B,E) . As the whole blood may contain a number of unspecified inflammatory factors as well as other non-neutrophil white blood cells, tracking of neutrophil extravasation and migration (via Hoechst staining) was less specific in whole blood, though the time scale (1 h) and migration speed suggest that extravasating cells should be neutrophils.
Conclusion
Through the use of robust organotypic design and a readily available iPSC-derived endothelial cell source, we have successfully demonstrated an in vitro model of a microvessel that displays lumen structure, barrier function, secretes angiogenic and inflammatory mediators, responds to its ECM and coculture, and supports immune cell (neutrophil) transendothelial extravasation and migration. Our microscale lumen culture approach directly synergizes with the advantages provided by commercial-iPSC endothelial cells. The LumeNEXT microculture approach allows the fabrication of 3D embedded lumens where size, structure, distance, and configuration are all tightly and precisely controlled using standard, widely available PDMS methods. Furthermore, devices are controlled and operated with no more than a micropipette and tweezers enabling low expertise operation and deployment in a variety of lab settings. Likewise, the iEC proved capable of physiological behaviors in organotypic culture, while also being simple to use and maintain. They require only standard culture techniques similar to those used with cell lines and were phenotypically robust over years of use with various lots. With this synergy, these iEC LumeNEXT microvessel models are accessible and amenable to large-scale integration and high throughput screening approaches, thus facilitating systemic investigations of the intrinsic regulators and potential clinically relevant compounds acting on the inflammatory recruitment of neutrophils through blood vessels. Neutrophil-endothelial interactions are critical in the regulation of neutrophil function and the innate immune response, and the demonstration of a tractable, robust, and physiologically relevant model of these interactions will prove useful as we work to unravel the complexity in neutrophil recruitment and resolution. The increased use of organotypic culture has the potential to greatly diminish the gap that is often observed between in vivo and in vitro models, improving investigations in cell biology and tissue engineering, as well as advancing personalized medicine and disease modeling. While primary cells from clinical patients can be hard to obtain regularly and reliably and may vary over time, iPSC can be used, maintaining physiological relevance and offering the opportunity to recapitulate disease phenotypes through genetic manipulation. Disease phenotypes A) Fluorescent microscopy (green -FITC-conjugated phalloidin, blueHoechst 33342) for the visualization of the 10 mg mL −1 fibrin iEC vessel cytoskeleton reveals alignment parallel to the vessel length, morphological elongation, and strong cortical actin expression, supporting tight cell-cell contact and vessel maturity. B) Fluorescent visualization of iEC vessels formed in 4 mg mL −1 collagen I matrices lacks obvious cortical actin or morphological elongation and alignment, and they display observable holes in the iEC microvessel monolayer (outlined in red). C) Permeability testing with 70 kDa FITC-dextran for collagen I ECM vessels highlights the leaky phenotype with observable dextran leakage through holes immediately after loading and significant diffusion by 10 min.
www.advancedsciencenews.com www.advhealthmat.de can be engineered using clustered regularly interspaced short palindromic repeat (CRISPR) Cas9 techniques, overexpression of dominant gene mutations in the iPSC parent lineage, or derivation of iPSC from individuals suffering from genetic syndromes directly. With complex organotypic multicultures, researchers can also derive all cellular components from the same genetic lineage. Looking toward the future, patient-specific models are not far off, considering the advances made in both microscale and organotypic culture and iPSC technology.
Experimental Section
Cell Culture: HUVECs were obtained from Lonza (Walkersville, Maryland) and maintained in endothelial basal media-2 (EBM-2) supplemented with the EGM-2 Bullet Kit (human EGF (hEGF), hydrocortisone, gentamicin, amphotericin-B, hVEGFa, hFGF-B, insulinlike growth factor 1 (R 3 -IGF-1), ascorbic acid, heparin, and fetal bovine serum to a final serum concentration of 2%). HUVECs were passaged with 0.05% trypsin with ethylenediaminetetraacetic acid (EDTA) (Thermo Fisher, Waltham, Massachusetts) prior to confluency and used through passage 7. Induced pluripotent stem cell-derived endothelial cells were obtained from Cellular Dynamics International (Madison, Wisconsin) and maintained in Vasculife Basal maintenance media from LifeLine Cell Technologies (Frederick, Maryland) supplemented with VEGFa, hEGF, hFGF-B, hIGF, ascorbic acid, hydrocortisone hemisuccinate, heparin sulfate, l-glutamine, and iCell Endothelial Cell Medium Supplement (Cellular Dynamics International). iPSC endothelial cells were passaged with 0.05% trypsin with EDTA (Thermo Fisher, Waltham, Massachusetts) prior to reaching confluency and used through passage 5. Prior to seeding of endothelial cells on any culture surfaces, a 30 µg mL −1 bovine fibronectin (Sigma-Aldrich, Saint Louis, Missouri) solution was incubated for 30 min on the culture surface to create fibronectin coatings for improved cell adherence. Human brain vascular pericytes from Sciencell (Carlsbad, California) were cultured in pericyte medium (ScienCell) on surfaces coated with poly-l-lysine (2 µg cm −2 , minimum incubation of 1 h) and passaged using 0.05% trypsin with EDTA (Thermo Fisher, Waltham, Massachusetts). Media were exchanged on each culture every other day, and all media used were filtered using a 500 mL, 0.2 µm polyethersulfone (PES) filter unit. Freezing for each cell type was performed in culture media supplemented with fetal bovine serum and dimethylsulfoxide (Sigma-Aldrich, Saint Louis, Missouri) in a 6:3:1 ratio, respectively.
Human Primary Endothelial Cell Isolation and Culture: Primary endothelial cells were isolated directly from human kidney tissue. After surgical resection, collected tissue samples were incubated with Lonza (Allansale, NJ) Eagle minimal essential media (MEM) with Earle's balanced salat solution (BSS), l-glutamine, 5 mg mL −1 collagenase, 5 mg mL −1 hyaluronidase, 1 mg mL −1 DNase, and 1% penicillin/ streptomycin for 4 h at 36 °C in a 5% CO 2 incubator. The dissociated tissue samples were filtered through a 100 µm filter, and cells were collected by centrifugation. Afterward, cells were washed three times with growth media (MEM media including 10% FBS, 1% penicillin/ streptomycin, 1% nonessential amino-acid solution (Thermo Fisher, Waltham, Massachusetts), 0.4 mg mL −1 hydrocortisone, and 5 µg mL −1 EGF). Endothelial cells were isolated using an anti-CD31-conjugated Adv. Healthcare Mater. 2018, 7, 1700497 Figure 5 . iEC microvessels support neutrophil extravasation and migration. A) Fluorescent microscopy of iEC lumen (green -calcein AM) shows successful extravasation and migration of labeled purified neutrophils toward an IL-8 source (top); individual iEC also migrate and sprout from the vessel formed in 5 mg mL −1 collagen I, but can be differentiated due to the lack of calcein stain. Image is displayed as a maximum intensity project across a Z-stack in order to visualize neutrophil migration in multiple planes. B) Maximum intensity project cell extravasation and migration from whole blood (blue -Hoechst 33342) in the iEC lumen. Migratory cells, likely to be neutrophils on this time scale, migrate both toward and away from IL-8 source when left as whole blood. C) Quantification of maximum migration distance shows purified neutrophils migrating significantly farther in response to 11 × 10 −6 m IL-8 (p = 0.0005, n = 4) than 10 × 10 −6 m fMLP. D) A less significant, but opposite trend regarding maximum migration distance (p = 0.0192, n = 4) is observed when using whole blood for neutrophil extravasation, with greater total migration observed using fMLP. E) Increased variability and decreased chemotactic effect (number of cells migrating up the gradient compared to total number of migrating cells) is observed with whole blood samples, likely contributing conflicting results. Purified neutrophils trend toward increased chemotactic effect with fMLP (p = 0.2925, not significant, n = 4) but significantly increase positive chemotaxis with IL-8 gradients (p ≤ 0.0001, n = 4).
www.advancedsciencenews.com www.advhealthmat.de magnetic microbead separation column as per the manufacturer's protocol (Miltenyi Biotech, Nycomed, Zürich, Switzerland). CD31 positive endothelial cells were cultured in growth media at 5% CO 2 and expanded and assayed for up to 4 passages, after which senescence limited growth and expansion. Human Primary Neutrophil Purification: Peripheral neutrophils from human blood were purified using the Miltenyi Biotech MACSxpress Neutrophil Isolation Kit according to the manufacturer's instructions (Nycomed, Zürich, Switzerland). All donors were healthy and informed consent was obtained at the time of the blood draw according to the requirements of the institutional review board (IRB). For identification, tracking, and viability monitoring, neutrophils were stained with calcein AM as per the manufacturer's protocol, prior to centrifugation and resuspension.
LumeNEXT Device Fabrication: The microfluidic organotypic culture platform was fabricated using the LumeNEXT approach previously reported by Jiménez-Torres et al. [14] Briefly, the LumeNEXT approach allows for fabrication of lumen structures where size, organization, distance, and configuration can be controlled using standard PDMS micromolding techniques and consists of two primary components: a culture chamber and a removable PDMS rod. Rods can be cast from molds or drawn from needles, with the gauge controlling lumen diameter. The chamber is formed by oxygen plasma bonding two distinct PDMS layers patterned using SU-8 on silicon master molds (SU8-100, MicroChem, Westborough, Massachusetts) onto a glass bottom MatTek dish (Ashland, Massachusetts). Each PDMS layer is patterned with two heights: deep (500 µm) features to form the chamber and ledge features (250 µm) to hold the rod across the middle of the culture chamber once the two layers are bonded together. PDMS layers were made using the Sylgard 184 silicone elastomer kit (Dow Corning, Auburn, Michigan) with a 10:1 curing agent ratio and plasma bonding was performed using a Diener Electronic Femto Plasma Surface System. While LumeNEXT provides considerable flexibility in device design and layout (e.g., branching and multilumen layouts), here single chamber, single lumen layouts interfaced with three types of ports were utilized: side ports, inlets, and outlets ( Figure 1A) , and with rods formed from 24 gauge (≈310 µm inner diameter), 23 gauge (≈340 µm inner diameter), and 17 gauge (≈100 µm inner diameter) needles. Rods were placed across the chamber body, from the small inlet port to the large outlet port, creating a lumen body of 2 mm in length. These ports were designed for passive pumping for both cell loading and media exchange and delivery. [50] Side ports, perpendicularly oriented, facilitated hydrogel/ ECM filling once the rod was in place. The final chamber size of 2 mm by 2.25 mm with a 1 mm height created a sufficiently large culture area where the lumen would be entirely surrounded by ECM. All port openings in this chamber were 400 µm across.
Device and ECM Preparation: Prior to ECM or cell loading, LumeNEXT devices were sterilized and prepped. Prebonded PDMS layers were Soxhlet extracted in 100% ethanol and soaked over several days to clean and remove uncured PDMS oligomers. After assembly, devices were UV sterilized for 30 min before being moved into a biosafety cabinet. In order to improve matrix adhesion on the PDMS surface within the chamber, the chamber was filled from the side ports with 1% polyethylenimine (Sigma-Aldrich, Saint Louis, Missouri) in deionized DI water for 10 min, followed by a 0.1% glutaraldehyde (Sigma-Aldrich, Saint Louis, Missouri) DI water solution. Device were then washed 5× with DI water to remove excess glutaraldehyde. Additional sacrificial phosphate buffered saline (PBS) was added around the sides of the MatTek dish and dishes were enclosed within Omnitrays to limit dehydration.
After surface preparation, devices were filled from the side ports with the desired matrix. Collagen I matrices were created by neutralizing Corning (Corning, New York) high concentration rat tail collagen I in a 1 to 1 ratio with 7.7 pH 2× PBS/4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) solution (Thermo Fisher, Waltham, Massachusetts) to create a ≈4 mg, 7.2 pH matrix. Once the mixed collagen solution was loaded into the chamber, devices remained at room temperature for 20 min to begin collagen polymerization before being moved into a cell culture incubator. When utilizing fibrin matrices, fibrinogen from bovine plasma (Sigma-Aldrich, Saint Louis, Missouri) was dissolved in Hanks buffered solution with calcium chloride and magnesium chloride (Thermo Fisher, Waltham, Massachusetts) to the desired fibrinogen concentration (5, 10 mg mL −1 ). Immediately prior to loading into the chamber, the fibrinogen solution was mixed with an appropriate volume of 50 U mL −1 thrombin from bovine plasma (SigmaAldrich, Saint Louis, Missouri) to achieve a final thrombin concentration of 1.25 U mL −1 . The enzymatic activity of thrombin quickly cleaves fibrinogen to facilitate formation of a fibrin matrix, so the solution must be mixed and dispensed into the chambers within 1 min. Devices were incubated at 36 °C for at least 1 h prior to cell loading.
Cell Loading: After incubation, devices were moved into a biosafety cabinet, and a drop of media was placed onto the inlet and outlet port over the lumen rod. Using tweezers, the rod could be easily pulled from the chamber, leaving behind a media-filled lumen within the ECM. LumeNEXT was originally demonstrated with collagen I matrices, and the compliance of both PDMS and collagen allowed high fidelity molding. When using the technique with significantly stiffer fibrin gels (kPa) [51] for iECs, an additional 1% pluronic F127 (Sigma-Aldrich, Saint Louis, Missouri) 30 min rod coating step was added to improve fidelity ( Figure S1 , Supporting Information). To encourage cell adhesion, 30 µg mL −1 bovine fibronectin (Sigma-Aldrich, Saint Louis, Missouri) was incubated in the lumen for 20 min in both collagen I and fibrin devices. Afterward, the lumen was washed with media 3×. The cells of interest were then trypsinized and resuspended to a concentration of 15 000 cells µL −1 and loaded into the open lumen via passive pumping. The lumens could then be placed into the cell culture incubator. Every 45 min, the MatTek bonded devices were flipped (upside-down, rightside-up, and so on) to allow cells to adhere around the entire lumen surface. After 4 h of incubation and flipping, unadhered cells could be aspirated from the lumen and replaced with fresh media.
Lumen Staining Protocol: As a result of the 3D microenvironment and extracellular matrix, significant background nonspecific fluorescence could be expected from antibody staining. As such, an extended staining protocol was required. First, media were removed from the lumens via aspiration, and the lumen was washed with 1× PBS (Thermo Fisher, Waltham, Massachusetts). After washing, the lumens were fixed with 4% paraformaldehyde (PFA) (Alfa Aesar, Ward Hill, Massachusetts) for 15 min and then washed three times with 1× PBS. When nonspecific binding in the 3D matrix is especially problematic, an additional roomtemperature incubation with 0.01 m glycine in PBS for 30 min can be added. Cell membranes were permeabilized with 0.2% triton X-100 (MP Biomedicals, Santa Ana, California) for 30 min followed by three 1× PBS wash steps. Subsequent blocking was performed by adding 3% bovine serum albumin (BSA, Sigma-Aldrich, Saint Louis, Missouri) to the lumens for overnight incubation. The following day, primary antibodies (e.g., CD31, P-selectin, I-CAM) could be added at a 1:50 dilution in 3% BSA and incubated for two nights. Afterward, the primary was removed and the lumens were washed with 0.1% tween 20 (Acros Organics, Geel, Belgium) in PBS at least three times, leaving the wash buffer overnight. The secondary animal-matched antibody could then be added 1:100 in BSA for a two night incubation prior to a final 3 × 0.1% tween in PBS wash steps. At this stage, Alexa conjugated phalloidin (Thermo Fisher, Waltham, Massachusetts) or Hoechst 33342 (Thermo Fisher, Waltham, Massachusetts) could be added 1:50 and incubated for 30 min for actin cytoskeletal staining or for nuclear staining, respectively. The LIVE/DEAD Cell Viability Assay (Thermo Fisher, Waltham, Massachusetts) was used as pre-manufacturer's protocol with an additional 3× wash in the evaluation of cell viability.
Image Acquisition: Bright-field and fluorescent images were obtained using a Nikon TI Eclipse inverted microscope (Melville, New York) and processed using Nikon Elements and the National Institutes of Health ImageJ software. Time-lapse imaging was performed on a Nikeon Eclipse TE300 (Melville, New York) scope and images were taken every 2 min over each time period in both phase and fluorescent illumination. Confocal images were acquired using a Leica SP8 (Wetzlar, Germany) in the University of Wisconsin, Madison Optical Imaging Core.
Neutrophil Extravasation and Chemotaxis Setup: Lumens were seeded with endothelial cells as described above and allowed to culture for 2 d with media exchange twice daily. Primary neutrophils were captured www.advancedsciencenews.com www.advhealthmat.de
Adv. Healthcare Mater. 2018, 7, 1700497 as described and, prior to loading, were dyed with calcein AM (Life Technologies) at 2.5 µg mL −1 for 10 min. Neutrophils were resuspended to a concentration of 2 × 10 7 cells mL −1 and were loaded into the lumens via passive pumping in a 1:1 mixture with culture media. Neutrophils were observed to both settle into the lumen body and attach along the side walls of the endothelium. Neutrophils were then signaled to extravasate and migrate through the addition of 3 µL chemoattractant source (fMLP, IL-8) onto the perpendicular side port, creating a gradient across the lumen body. Lumens were immediately imaged using the Nikeon Eclipse TE300 and fluorescent microscopy. MagPix Secretion Analysis: Multiplexed protein secretion analysis was performed on primary and iPSC-derived in vitro vessels using the MagPix Luminex Xmap (Luminex Corporation, Austin, Texas) with the Milliplex human angiogenesis growth factor panel bead kit (EMD Millipore, Billerica, Massachusetts) as per the manufacturer's protocol. Conditioned maintenance media were retrieved twice daily on days 1 and 2 from three replicates of vessels using a p10 pipette, yielding 2 µL per lumen. Maintenance media were also extracted from empty lumen devices (i.e., no endothelium) for normalization, and the media collected from days 1 and 2 were combined to increase sample volume in each condition. Data from the MAGPIX assay were calculated using mean fluorescence intensities.
Atomic Force Microscopy: Gel stiffness was measure utilizing atomic force microscopy (AFM). 10 mg mL −1 fibrin gels were prepared as described above on open well glass substrates, and measurements were taken using a Bruker Catalyst Bioscope AFM at the Material Science Center at the University of Wisconsin, Madison. At least ten force curves were generated for each of four fibrin samples using a 5 µm borosilicate bead tipped probe from NovaScan (Ames, IA) to determine the Young's modulus.
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